Greater than 90.0% as determined by SDS-PAGE.
B2M is a small protein consisting of 119 amino acids. It is non-covalently associated with the alpha chains of MHC class I molecules. This association is critical for the stability and function of the MHC class I complex. The MHC class I molecules display fragments of proteins from within the cell on the cell surface. This allows T-cells to monitor the health of cells and detect any that are infected with viruses or have become cancerous .
Recombinant human B2M is produced using various expression systems, including E. coli and HEK293 cells. The recombinant protein is often tagged with a polyhistidine (His) tag to facilitate purification. After expression, the protein is purified to high levels of purity, typically greater than 95%, as determined by methods such as SDS-PAGE and HPLC .
B2M levels in the blood and urine can be used as a biomarker for various diseases. Elevated levels of B2M are associated with certain cancers, including multiple myeloma and lymphoma, as well as kidney diseases. It is also used as a marker for monitoring the progression of these diseases and the effectiveness of treatments .
Recombinant B2M is used in various research and clinical applications. It is utilized in studies related to the immune system, cancer research, and the development of diagnostic assays. The protein’s role in antigen presentation makes it a valuable tool for understanding immune responses and developing new therapeutic strategies .